Rohto Pharmaceutical Co.,Ltd. (4527.T)
JPY 2220.0
(-0.11%)
JPY 2220.0
(-0.11%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 117.23 Billion JPY | 10.93% |
| 2022 | 103.45 Billion JPY | 18.73% |
| 2021 | 87.13 Billion JPY | 4.06% |
| 2020 | 83.73 Billion JPY | -8.67% |
| 2019 | 91.67 Billion JPY | 3.23% |
| 2018 | 88.8 Billion JPY | 8.36% |
| 2017 | 81.95 Billion JPY | 8.0% |
| 2016 | 75.88 Billion JPY | -9.16% |
| 2015 | 83.54 Billion JPY | 7.89% |
| 2014 | 77.43 Billion JPY | 11.69% |
| 2013 | 69.33 Billion JPY | 12.75% |
| 2012 | 61.48 Billion JPY | 33.59% |
| 2011 | 46.02 Billion JPY | 4.27% |
| 2010 | 44.14 Billion JPY | -0.04% |
| 2009 | 44.16 Billion JPY | 1.85% |
| 2008 | 43.36 Billion JPY | 4.16% |
| 2007 | 41.62 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q1 | 27.28 Billion JPY | -10.89% |
| 2023 Q4 | 30.62 Billion JPY | 5.34% |
| 2023 FY | 114.76 Billion JPY | 10.93% |
| 2023 Q1 | 24.47 Billion JPY | -20.06% |
| 2023 Q2 | 28.51 Billion JPY | 16.48% |
| 2023 Q3 | 29.06 Billion JPY | 1.94% |
| 2022 Q1 | 21.29 Billion JPY | -20.22% |
| 2022 Q4 | 30.62 Billion JPY | 15.0% |
| 2022 Q3 | 26.62 Billion JPY | 6.85% |
| 2022 FY | 103.45 Billion JPY | 18.73% |
| 2022 Q2 | 24.91 Billion JPY | 17.03% |
| 2021 Q2 | 20.57 Billion JPY | 13.54% |
| 2021 Q4 | 26.69 Billion JPY | 22.68% |
| 2021 Q3 | 21.75 Billion JPY | 5.76% |
| 2021 FY | 87.13 Billion JPY | 4.06% |
| 2021 Q1 | 18.11 Billion JPY | -24.61% |
| 2020 FY | 83.73 Billion JPY | -8.67% |
| 2020 Q1 | 18.48 Billion JPY | -31.45% |
| 2020 Q3 | 21.47 Billion JPY | 8.74% |
| 2020 Q2 | 19.74 Billion JPY | 6.83% |
| 2020 Q4 | 24.03 Billion JPY | 11.93% |
| 2019 Q2 | 22.73 Billion JPY | 11.23% |
| 2019 Q4 | 26.96 Billion JPY | 25.14% |
| 2019 FY | 91.67 Billion JPY | 3.23% |
| 2019 Q1 | 20.43 Billion JPY | -20.81% |
| 2019 Q3 | 21.54 Billion JPY | -5.23% |
| 2018 Q3 | 21.77 Billion JPY | -2.71% |
| 2018 FY | 88.8 Billion JPY | 8.36% |
| 2018 Q4 | 25.8 Billion JPY | 18.54% |
| 2018 Q2 | 22.37 Billion JPY | 18.73% |
| 2018 Q1 | 18.84 Billion JPY | -24.74% |
| 2017 Q3 | 20.33 Billion JPY | 2.69% |
| 2017 FY | 81.95 Billion JPY | 8.0% |
| 2017 Q1 | 16.77 Billion JPY | -27.05% |
| 2017 Q4 | 25.04 Billion JPY | 23.16% |
| 2017 Q2 | 19.8 Billion JPY | 18.04% |
| 2016 Q2 | 18.65 Billion JPY | 13.71% |
| 2016 Q3 | 17.82 Billion JPY | -4.46% |
| 2016 Q4 | 22.99 Billion JPY | 29.03% |
| 2016 FY | 75.88 Billion JPY | -9.16% |
| 2016 Q1 | 16.4 Billion JPY | -31.48% |
| 2015 FY | 83.54 Billion JPY | 7.89% |
| 2015 Q4 | 23.94 Billion JPY | 12.5% |
| 2015 Q3 | 21.28 Billion JPY | 7.54% |
| 2015 Q2 | 19.79 Billion JPY | 6.95% |
| 2015 Q1 | 18.5 Billion JPY | -19.66% |
| 2014 Q4 | 23.03 Billion JPY | 13.76% |
| 2014 FY | 77.43 Billion JPY | 11.69% |
| 2014 Q1 | 16.74 Billion JPY | -18.88% |
| 2014 Q2 | 17.4 Billion JPY | 3.94% |
| 2014 Q3 | 20.25 Billion JPY | 16.36% |
| 2013 Q4 | 20.63 Billion JPY | 16.72% |
| 2013 FY | 69.33 Billion JPY | 12.75% |
| 2013 Q1 | 15.06 Billion JPY | -14.58% |
| 2013 Q2 | 15.94 Billion JPY | 5.84% |
| 2013 Q3 | 17.68 Billion JPY | 10.91% |
| 2012 Q1 | 13.8 Billion JPY | 136.72% |
| 2012 Q4 | 17.63 Billion JPY | 15.81% |
| 2012 Q2 | 14.81 Billion JPY | 7.31% |
| 2012 Q3 | 15.22 Billion JPY | 2.77% |
| 2012 FY | 61.48 Billion JPY | 33.59% |
| 2011 Q2 | 13.81 Billion JPY | 13.31% |
| 2011 Q3 | 14.18 Billion JPY | 2.62% |
| 2011 Q4 | 5.83 Billion JPY | -58.87% |
| 2011 FY | 46.02 Billion JPY | 4.27% |
| 2011 Q1 | 12.19 Billion JPY | 123.33% |
| 2010 FY | 44.14 Billion JPY | -0.04% |
| 2010 Q1 | 11.72 Billion JPY | 111.42% |
| 2010 Q2 | 13.13 Billion JPY | 12.08% |
| 2010 Q3 | 13.85 Billion JPY | 5.49% |
| 2010 Q4 | 5.46 Billion JPY | -60.59% |
| 2009 Q2 | 13.04 Billion JPY | 9.74% |
| 2009 FY | 44.16 Billion JPY | 1.85% |
| 2009 Q1 | 11.88 Billion JPY | 212.13% |
| 2009 Q4 | 5.54 Billion JPY | -59.54% |
| 2009 Q3 | 13.7 Billion JPY | 5.02% |
| 2008 Q3 | 13.93 Billion JPY | 1.66% |
| 2008 Q2 | 13.71 Billion JPY | 0.0% |
| 2008 Q4 | 3.8 Billion JPY | -72.67% |
| 2008 FY | 43.36 Billion JPY | 4.16% |
| 2007 FY | 41.62 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Kitanotatsujin Corporation | 9.38 Billion JPY | -1149.458% |
| Euglena Co., Ltd. | 34.45 Billion JPY | -240.294% |
| BEAUTY GARAGE Inc. | 5.8 Billion JPY | -1921.256% |
| Axas Holdings Co.,Ltd. | 3 Billion JPY | -3807.363% |
| C.I. Medical Co.,Ltd. | 9 Billion JPY | -1201.777% |
| Kao Corporation | 438.95 Billion JPY | 73.291% |
| Niitaka Co., Ltd. | 6.65 Billion JPY | -1660.395% |
| Shiseido Company, Limited | 696.62 Billion JPY | 83.171% |
| Lion Corporation | 160.09 Billion JPY | 26.769% |
| Mandom Corporation | 29.51 Billion JPY | -297.282% |
| Ivy Cosmetics Corporation | 1.72 Billion JPY | -6694.937% |
| Milbon Co., Ltd. | 24 Billion JPY | -388.49% |
| Nippon Shikizai, Inc. | 2.31 Billion JPY | -4971.381% |
| Fancl Corporation | 61.61 Billion JPY | -90.263% |
| KOSÉ Corporation | 189.85 Billion JPY | 38.25% |
| Cota Co., Ltd. | 4.25 Billion JPY | -2656.507% |
| HABA Laboratories,Inc. | 8.21 Billion JPY | -1327.324% |
| C'bon Cosmetics Co.,Ltd. | 6.37 Billion JPY | -1740.311% |
| Pola Orbis Holdings Inc. | 119.68 Billion JPY | 2.045% |
| Noevir Holdings Co., Ltd. | 31.54 Billion JPY | -271.712% |
| Adjuvant Holdings Co.,Ltd. | 2.86 Billion JPY | -3996.874% |
| Almado, Inc. | 4.11 Billion JPY | -2752.15% |
| I-ne CO., LTD. | 17.86 Billion JPY | -556.244% |
| Premier Anti-Aging Co., Ltd. | 15.96 Billion JPY | -634.528% |
| Liberta Co.,Ltd. | 2.68 Billion JPY | -4272.717% |
| AXXZIA Inc. | 8.57 Billion JPY | -1267.619% |
| S.T. Corporation | 15.07 Billion JPY | -677.801% |
| Kobayashi Pharmaceutical Co., Ltd. | 70.59 Billion JPY | -66.069% |
| Earth Corporation | 57.25 Billion JPY | -104.765% |
| Sagami Rubber Industries Co., Ltd. | 1.57 Billion JPY | -7363.828% |
| Asahi Eito Holdings Co.,Ltd. | 1.29 Billion JPY | -8928.997% |
| Ya-Man Ltd. | 18.49 Billion JPY | -533.779% |
| MTG Co., Ltd. | 33.26 Billion JPY | -252.468% |
| TRANSACTION CO.,Ltd. | 4.57 Billion JPY | -2461.762% |
| SHOBIDO Corporation | 4.5 Billion JPY | -2505.068% |
| Artnature Inc. | 25.01 Billion JPY | -368.671% |
| Pigeon Corporation | 34.72 Billion JPY | -237.599% |
| Unicharm Corporation | 351.52 Billion JPY | 66.649% |
| Paltac Corporation | 53.06 Billion JPY | -120.945% |
| CB GROUP MANAGEMENT Co., Ltd. | 13.78 Billion JPY | -750.475% |